Prevalence data from sources such as population surveys can be a useful complement to case based surveillance data for hepatitis B. Case-based surveillance has limitations as most diagnosed cases are chronic in nature and detection of cases depends largely on testing practices. Prevalence data can therefore contribute towards a fuller understanding of the epidemiology of hepatitis B.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 5-11 June 2023 and includes updates on Middle East respiratory syndrome coronavirus (MERS-CoV), COVID-19, Mpox, Marburg virus disease and West Nile virus.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 28 May - 3 June 2023 and includes updates on COVID-19, West Nile virus, Legionnaires' disease, avian influenza, Marburg virus disease, cholera, and fungal meningitis.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 21-27 May 2023 and includes updates on COVID-19, influenza, Marburg virus disease, poliomyelitis, extensively drug-resistant Pseudomonas aeruginosa, and suspected fungal meningitis.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 14-17 May 2023 and includes updates on Legionnaires’ disease, avian or animal influenza (H5), MDR S.Typhi, Marburg virus disease and antifungal-resistant Trichophyton indotineae.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 7-13 May 2023 and includes updates on measles, COVID-19, influenza and swine influenza, group A Streptococcal infection, Marburg virus disease, Lassa fever, diphtheria and mpox.